Well said Markus. I don't regret my Erbitux even though it geometrically increased my radiation dermatitis, but it's a question of 20/20 hindsight. After the same tumor came back, my RO concluded that it was Erbitux resistant. My frustration is that they have not developed a test for head and neck tumors similar to the KRAS gene test for colo rectal cancer so in effect an Erbitux only regime for OCF patients is a crap shoot. At the time of my treatment however, all the studies indicated it was a viable option and even the FDA said so. Too wise too late.
Charm